Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2007 | 1 |
| 2025 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial.
Clin Breast Cancer. 2025 Aug;25(6):560-565.e2. doi: 10.1016/j.clbc.2025.05.003. Epub 2025 May 13.
Clin Breast Cancer. 2025.
PMID: 40500613
Clinical Trial.
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy.
Benigni A, Daina E, Löffler-Wirth H, Piras R, Rigoldi M, Schmidt M, Carrara C, Donadelli R, Imanifard Z, Mele C, Alberti M, Marasà M, Martinatto C, Bresin E, Res SG, Quadri L, Nanchen G, Vivarelli M, Emma F, La Manna G, Vidal E, Pasini A, Ranghino A, Donati G, Verrina E, Angeletti A, Brunori G, Giordano M, Alberici F, Maggiore U, Malgieri G, Remuzzi G, Breno M, Noris M; Italian Registry of MPGN.
Benigni A, et al.
Kidney Int. 2025 Oct 9:S0085-2538(25)00772-0. doi: 10.1016/j.kint.2025.08.035. Online ahead of print.
Kidney Int. 2025.
PMID: 41076080
Free article.
Item in Clipboard
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.
Vincenzi B, Santini D, Russo A, Gavasci M, Battistoni F, Dicuonzo G, Rocci L, Rosaria VM, Gebbia N, Tonini G.
Vincenzi B, et al. Among authors: rosaria vm.
Pharmacogenomics. 2007 Apr;8(4):319-27. doi: 10.2217/14622416.8.4.319.
Pharmacogenomics. 2007.
PMID: 17391070
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.